Literature DB >> 12079899

Autoantibodies against interleukin 1alpha in rheumatoid arthritis: association with long term radiographic outcome.

N A Graudal1, M Svenson, U Tarp, P Garred, A-G Jurik, K Bendtzen.   

Abstract

OBJECTIVES: To investigate the possible association of interleukin 1alpha autoantibodies (IL1alpha aAb) with the long term course of joint erosion in patients with rheumatoid arthritis (RA).
METHODS: Serum samples from 176 patients with RA included in a prospective study over 30 years were analysed for IL1alpha aAb by binding to human [(125)I]IL1alpha. Erosions of 19 diarthrodial joints were radiographically scored by the Larsen method.
RESULTS: The relative risk (RR) of early IL1alpha aAb positive patients developing at least 30% of maximum radiographic joint destruction was significantly lower than for IL1alpha aAb negative patients, RR=0.29 (p=0.04). In rheumatoid factor positive patients RR was only 0.18 (p=0.02). Patients who seroconverted more than two years after the onset of RA showed the most aggressive development of joint erosion, with a relative risk of at least 40% of maximum radiographic joint destruction of 2.56 (p=0.048)
CONCLUSIONS: The progression of radiographic joint destruction in patients with RA is associated with, and perhaps modified by, circulating IL1alpha aAb, suggesting that IL1alpha or IL1alpha aAb, or both, have a role in the erosive processes. IL1alpha aAb appear to be of prognostic significance in RA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079899      PMCID: PMC1754172          DOI: 10.1136/ard.61.7.598

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  40 in total

Review 1.  Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFalpha treatment.

Authors:  G Harriman; L K Harper; T F Schaible
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis.

Authors:  J A Eastgate; J A Symons; N C Wood; F M Grinlinton; F S di Giovine; G W Duff
Journal:  Lancet       Date:  1988-09-24       Impact factor: 79.321

3.  Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.

Authors:  A Larsen; K Dale; M Eek
Journal:  Acta Radiol Diagn (Stockh)       Date:  1977-07

4.  Inflammatory patterns in rheumatoid arthritis estimated by the number of swollen and tender joints, the erythrocyte sedimentation rate, and hemoglobin: longterm course and association to radiographic progression.

Authors:  N Graudal; U Tarp; A G Jurik; A M Galløe; P Garred; N Milman; H K Graudal
Journal:  J Rheumatol       Date:  2000-01       Impact factor: 4.666

5.  IgG autoantibodies against interleukin 1 alpha in sera of normal individuals.

Authors:  M Svenson; L K Poulsen; A Fomsgaard; K Bendtzen
Journal:  Scand J Immunol       Date:  1989-04       Impact factor: 3.487

6.  Increased incidence of autoantibodies to interleukin-1a in rheumatoid arthritis with interstitial lung disease.

Authors:  K Maniwa; F Ogushi; K Tani; Y Ohmoto; M Muraguchi; S Sone
Journal:  Respirology       Date:  2000-12       Impact factor: 6.424

7.  Arthritis induced by continuous infusion of hr-interleukin-1 alpha into the rabbit knee-joint.

Authors:  U Feige; A Karbowski; C Rordorf-Adam; A Pataki
Journal:  Int J Tissue React       Date:  1989

8.  A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.

Authors:  Y Jiang; H K Genant; I Watt; M Cobby; B Bresnihan; R Aitchison; D McCabe
Journal:  Arthritis Rheum       Date:  2000-05

9.  In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice.

Authors:  J T Hom; A M Bendele; D G Carlson
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

10.  Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice.

Authors:  R Horai; S Saijo; H Tanioka; S Nakae; K Sudo; A Okahara; T Ikuse; M Asano; Y Iwakura
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

View more
  16 in total

1.  Anti-interleukin 1alpha autoantibodies.

Authors:  P Miossec
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

2.  Anti-cytokine autoantibodies in autoimmune diseases.

Authors:  Giuseppe Cappellano; Elisabetta Orilieri; Abiy D Woldetsadik; Elena Boggio; Maria F Soluri; Cristoforo Comi; Daniele Sblattero; Annalisa Chiocchetti; Umberto Dianzani
Journal:  Am J Clin Exp Immunol       Date:  2012-11-15

Review 3.  Autoantibodies and other serological markers in rheumatoid arthritis: predictors of disease activity?

Authors:  Licia Maria Henrique da Mota; Leopoldo Luiz dos Santos Neto; Jozélio Freire de Carvalho
Journal:  Clin Rheumatol       Date:  2009-07-14       Impact factor: 2.980

4.  A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.

Authors:  S B Cohen; L W Moreland; J J Cush; M W Greenwald; S Block; W J Shergy; P S Hanrahan; M M Kraishi; A Patel; G Sun; M B Bear
Journal:  Ann Rheum Dis       Date:  2004-04-13       Impact factor: 19.103

5.  Mining the human autoantibody repertoire: isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymoma.

Authors:  Roger R Beerli; Monika Bauer; Andrea Fritzer; Lindsey B Rosen; Regula B Buser; Markus Hanner; Melanie Maudrich; Mario Nebenfuehr; Jorge Alejandro Sepulveda Toepfer; Susanne Mangold; Anton Bauer; Steven M Holland; Sarah K Browne; Andreas Meinke
Journal:  MAbs       Date:  2014       Impact factor: 5.857

6.  Prognostic laboratory markers of joint damage in rheumatoid arthritis.

Authors:  E Lindqvist; K Eberhardt; K Bendtzen; D Heinegård; T Saxne
Journal:  Ann Rheum Dis       Date:  2004-09-30       Impact factor: 19.103

7.  Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases.

Authors:  Sarthak Gupta; Ioanna P Tatouli; Lindsey B Rosen; Sarfaraz Hasni; Ilias Alevizos; Zerai G Manna; Juan Rivera; Chao Jiang; Richard M Siegel; Steven M Holland; Haralampos M Moutsopoulos; Sarah K Browne
Journal:  Arthritis Rheumatol       Date:  2016-07       Impact factor: 10.995

8.  Autoantibodies against interleukin-21 correlate with disease activity in patients with rheumatoid arthritis.

Authors:  Rui Xing; Lin Sun; Dong Wu; Yinji Jin; Changhong Li; Xiangyuan Liu; Jinxia Zhao
Journal:  Clin Rheumatol       Date:  2017-10-10       Impact factor: 2.980

9.  Autoantibodies induced by chimeric cytokine-HIV envelope glycoprotein immunogens.

Authors:  Gözde Isik; Thijs van Montfort; Nancy P Y Chung; John P Moore; Rogier W Sanders
Journal:  J Immunol       Date:  2014-04-11       Impact factor: 5.422

10.  Enhanced immunogenicity of HIV-1 envelope gp140 proteins fused to APRIL.

Authors:  Gözde Isik; Kwinten Sliepen; Thijs van Montfort; Rogier W Sanders
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.